Federal Register of Legislation - Australian Government

Primary content

PB 11 of 2010 Specifications as made
This Specification amends the National Health Act (Pharmaceutical Benefits - Early Supply) - specification under subsection 84AAA(2) Instrument 2009 (No. PB 30 of 2009) to provide pharmaceutical benefits that can be resupplied inside 20 days on the one prescription.
Administered by: Health
Registered 25 Feb 2010
Tabling HistoryDate
Tabled HR09-Mar-2010
Tabled Senate09-Mar-2010
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

COMMONWEALTH OF AUSTRALIA

Instrument number PB 11 of 2010

National Health (Pharmaceutical Benefits – Early Supply) Amendment March 2010 - Specification Under Subsection 84AAA(2)

 

Amendment determination under subsection 84AAA(2) of the National Health Act 1953

 

I, Felicity McNeill, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

 

Dated                    22      February 2010

 

 

FELICITY MCNEILL

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

 

 

 

Amendment determination — Pharmaceutical Benefits - Early Supply

 

 

1          Name of Instrument

 

(1)           This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment March 2010 - specification under subsection 84AAA(2).

 

(2)           This Instrument may also be cited as “No. PB 11 of 2010”.


 

2          Commencement

 

This Instrument commences on 1 March 2010.

 

 

3          Amendment of PB 30 of 2009

 

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009, PB 30 of 2009.

 


Schedule 1        Amendments

[1]                                  Schedule 1, after item dealing with Candesartan with hydrochlorothiazide, Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg

insert in the columns in the order indicated:

 

 

Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg

Oral

30

5

 

Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg

Oral

30

5

 

 

[2]                                  Schedule 1, after item dealing with Gemfibrozil

insert in the columns in the order indicated:

 

Gliclazide

Tablet 60 mg (modified release)

Oral

60

5

 

 

[3]                                  Schedule 1, after item dealing with Moxonidine

insert in the columns in the order indicated:

 

Nebivolol

Tablet 1.25 mg (as hydrochloride), 28

Oral

1

5

 

Tablet 1.25 mg (as hydrochloride)

Oral

56

5

 

Tablet 5 mg (as hydrochloride)

Oral

28

5

 

Tablet 10 mg (as hydrochloride)

Oral

28

5